Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Apr 20;13(4):e14591.
doi: 10.7759/cureus.14591.

Ulcerative Colitis With Concomitant Serrated Polyposis Syndrome: A Case Report and Literature Review

Mahmoud M Mansour  1 , Zachary D Smith  2 , Yezaz Ghouri  2 , Veysel Tahan  2
Affiliations
Case Reports

Ulcerative Colitis With Concomitant Serrated Polyposis Syndrome: A Case Report and Literature Review

Mahmoud M Mansour et al. Cureus. .

Abstract

Serrated polyposis syndrome (SPS) is a pre-cancerous condition associated with increased risk of developing colorectal cancer (CRC). Its role in inflammatory bowel disease (IBD)-associated CRC remains unknown. Despite the growing understanding and recognition of SPS, there is limited literature about its impact on the colon in individuals with IBD. Herein, we report a case of a 45-year-old female who was diagnosed with ulcerative colitis (UC) and SPS. We also reviewed the literature surrounding this association and highlighted the intricacies in managing this unique patient population. At present, there are no screening guidelines for CRC in SPS patients with IBD. However, given the potential synergistic risk for CRC, a close surveillance approach may be utilized. Tracking lifetime cumulative features of SPS and endoscopic clearance of adenomas and serrated polyps are the mainstays of management.

Keywords: colorectal cancer (crc); inflammatory bowel disease; serrated polyp; serrated polyposis syndrome (sps); sessile serrated adenoma; ulcerative colitis (uc).

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Ascending colon sessile serrated adenoma/polyp
A: Endoscopic view showing ascending colon sessile serrated adenomatous polyp B: Hematoxylin-eosin stain of the resected specimen of sessile serrated adenoma without cytologic dysplasia showing the presence of serrated crypts and irregularly dilated and branching crypts.
Figure 2
Figure 2. Proctitis; inflammation of the rectal mucosa
A: Endoscopic view showing moderate rectal erythema and muco-purulent discharge. B: Hematoxylin-eosin stain of the rectal biopsy specimen showing active proctitis. A crypt abscess (arrow) is visible.
See this image and copyright information in PMC

References

    1. Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case-control IG-IBD study. Biancone L, Armuzzi A, Scribano ML, et al. Inflamm Bowel Dis. 2020;26:450–459. - PubMed
    1. European consensus on the histopathology of inflammatory bowel disease. Magro F, Langner C, Driessen A, et al. J Crohns Colitis. 2013;7:827–851. - PubMed
    1. Gastrointestinal pathology. Mod Pathol. 2017;30:157–210. - PubMed
    1. The 2019 WHO classification of tumours of the digestive system. Nagtegaal ID, Odze RD, Klimstra D, et al. Histopathology. 2020;76:182–188. - PMC - PubMed
    1. Hyperplastic polyposis of the colon and rectum. Renaut AJ, Douglas PR, Newstead GL. Colorectal Dis. 2002;4:213–215. - PubMed

Publication types

LinkOut - more resources